Maximum quantity allowed is 999
Please select the quantity
CAS RN: 211555-04-3 | Product Number: W0013
WHI-P154
Purity: >98.0%(HPLC)
Synonyms:
- 2-Bromo-4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenol
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days |
---|---|---|---|
10MG |
A$352.00
|
5 | ≥40 |
50MG |
A$1,070.00
|
8 | 34 |
* Please contact our distributor of Chem-Supply
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination.
* ChemSupply Australia Pty Ltd (Phone: 08-8440-2000 / email: sales@chemsupply.com.au)
* ChemSupply Australia Pty Ltd (Phone: 08-8440-2000 / email: sales@chemsupply.com.au)
Product Number | W0013 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__6H__1__4BrN__3O__3 = 376.21 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 211555-04-3 |
Reaxys Registry Number | 8787580 |
PubChem Substance ID | 468593122 |
MDL Number | MFCD02179366 |
Specifications
Appearance | White to Yellow to Orange powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Melting point | 228.0 to 232.0 °C |
Elemental analysis(Nitrogen) | 10.50 to 11.50 % |
NMR | confirm to structure |
Properties (reference)
Melting Point | 230 °C |
Maximum Absorption Wavelength | 335(MeOH) nm |
GHS
Hazard Statements | H413 : May cause long lasting harmful effects to aquatic life. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. |
Related Laws:
Transport Information:
H.S.code* | 2933.59-000 |
Application
WHI-P 154: A Potent Janus-Associated Kinase 3 (JAK3) Inhibitor
WHI-P 154 is a potent Janus-associated kinase 3 (JAK3) inhibitor that displays no activity at JAK1 or JAK2. JAK3 is a cytoplasmic protein tyrosine kinase that functions in the initiation of cytokine-triggered signal transduction by catalyzing the phosphorylation of signal transduction and activators of transcription (STAT). The phosphorylated SATAs are translocated to the nucleus to activate target genes. WHI-P 154 is cytotoxic human glioblastoma cells. Recent reports have indicated that JAK3 is expressed in lymphoid cells and is involved in the signaling of T cell functions. Therefore, the development of a selective JAK3 inhibitor has been shown to have a potential benefit in the treatment of autoimmune disorders. (The product is for research purpose only.)
References
- 4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells
- Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3
- The specificity of JAK3 kinase inhibitors
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.